253 related articles for article (PubMed ID: 16938887)
41. Druggable Targets in Endocannabinoid Signaling.
Gregus AM; Buczynski MW
Adv Exp Med Biol; 2020; 1274():177-201. PubMed ID: 32894511
[TBL] [Abstract][Full Text] [Related]
42. Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination.
Maner-Smith KM; Goll JB; Khadka M; Jensen TL; Colucci JK; Gelber CE; Albert CJ; Bosinger SE; Franke JD; Natrajan M; Rouphael N; Johnson RA; Sanz P; Anderson EJ; Hoft DF; Mulligan MJ; Ford DA; Ortlund EA
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32722213
[TBL] [Abstract][Full Text] [Related]
43. Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.
Reddy V; Grogan D; Ahluwalia M; Salles ÉL; Ahluwalia P; Khodadadi H; Alverson K; Nguyen A; Raju SP; Gaur P; Braun M; Vale FL; Costigliola V; Dhandapani K; Baban B; Vaibhav K
EPMA J; 2020 Jun; 11(2):217-250. PubMed ID: 32549916
[TBL] [Abstract][Full Text] [Related]
44. Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
Charytoniuk T; Zywno H; Konstantynowicz-Nowicka K; Berk K; Bzdega W; Chabowski A
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545780
[TBL] [Abstract][Full Text] [Related]
45. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
46. Molecular Mechanism and Cannabinoid Pharmacology.
Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
[TBL] [Abstract][Full Text] [Related]
47. Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain.
Hossain MZ; Ando H; Unno S; Kitagawa J
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093166
[TBL] [Abstract][Full Text] [Related]
48. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.
Manca C; Boubertakh B; Leblanc N; Deschênes T; Lacroix S; Martin C; Houde A; Veilleux A; Flamand N; Muccioli GG; Raymond F; Cani PD; Di Marzo V; Silvestri C
J Lipid Res; 2020 Jan; 61(1):70-85. PubMed ID: 31690638
[TBL] [Abstract][Full Text] [Related]
49. Comparative studies of endocannabinoid modulation of pain.
Paulsen RT; Burrell BD
Philos Trans R Soc Lond B Biol Sci; 2019 Nov; 374(1785):20190279. PubMed ID: 31544609
[TBL] [Abstract][Full Text] [Related]
50. Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder.
Wu MM; Zhang X; Asher MJ; Thayer SA
Brain Res; 2019 Dec; 1724():146467. PubMed ID: 31539547
[TBL] [Abstract][Full Text] [Related]
51. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
[TBL] [Abstract][Full Text] [Related]
52. Lipokines and Thermogenesis.
Lynes MD; Kodani SD; Tseng YH
Endocrinology; 2019 Oct; 160(10):2314-2325. PubMed ID: 31504387
[TBL] [Abstract][Full Text] [Related]
53. Expression of type I mGluRs predicts plasticity in the hippocampal stratum radiatum interneurons.
Nufer TM; Merrill C; Friend L; Hopkins Z; Boyce Z; Edwards JG
Neurosci Lett; 2019 Nov; 712():134472. PubMed ID: 31499135
[TBL] [Abstract][Full Text] [Related]
54. Dual inhibition of cannabinoid CB
Udi S; Hinden L; Ahmad M; Drori A; Iyer MR; Cinar R; Herman-Edelstein M; Tam J
Br J Pharmacol; 2020 Jan; 177(1):110-127. PubMed ID: 31454063
[TBL] [Abstract][Full Text] [Related]
55. Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome.
Di Marzo V; Silvestri C
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31434293
[TBL] [Abstract][Full Text] [Related]
56. Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory.
Li RS; Fukumori R; Takeda T; Song Y; Morimoto S; Kikura-Hanajiri R; Yamaguchi T; Watanabe K; Aritake K; Tanaka Y; Yamada H; Yamamoto T; Ishii Y
Sci Rep; 2019 Jul; 9(1):9621. PubMed ID: 31270353
[TBL] [Abstract][Full Text] [Related]
57. Hippocampal Stratum Oriens Somatostatin-Positive Cells Undergo CB1-Dependent Long-Term Potentiation and Express Endocannabinoid Biosynthetic Enzymes.
Friend LN; Williamson RC; Merrill CB; Newton ST; Christensen MT; Petersen J; Wu B; Ostlund I; Edwards JG
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987110
[TBL] [Abstract][Full Text] [Related]
58. Perspectives on the Role of Endocannabinoids in Autism Spectrum Disorders.
Yeh ML; Levine ES
OBM Neurobiol; 2017; 1(2):. PubMed ID: 30854511
[TBL] [Abstract][Full Text] [Related]
59. Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.
Tóth KF; Ádám D; Bíró T; Oláh A
Molecules; 2019 Mar; 24(5):. PubMed ID: 30845666
[TBL] [Abstract][Full Text] [Related]
60. Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice.
Dobranowski PA; Tang C; Sauvé JP; Menzies SC; Sly LM
Gut Microbes; 2019; 10(5):578-598. PubMed ID: 30760087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
